How to classify biotech news


1. By Source Type

  • Press release (corporate communication) – company announcements about trials, partnerships, funding.
  • Original reporting (journalism) – investigative articles, analyst commentary, interviews.
  • Scientific publication – peer-reviewed journal papers, preprints.
  • Regulatory update – FDA/EMA approvals, guidance changes.

2. By Stage of Development

  • Discovery & preclinical research – basic science, early lab studies, animal models.
  • Clinical trials
    • Phase I – safety
    • Phase II – efficacy
    • Phase III – pivotal/confirmatory
    • Phase IV – post-marketing studies
  • Regulatory milestones – IND/CTA filings, orphan drug designation, approvals.
  • Commercial stage – launches, sales reports, manufacturing scale-up.

3. By Scientific/Technological Focus

  • Therapeutic modality –
    • Small molecules
    • Biologics (antibodies, proteins)
    • Cell therapy
    • Gene therapy
    • RNA therapeutics (mRNA, siRNA, ASO)
  • Platform/technology –
    • CRISPR/gene editing
    • AI/ML in drug discovery
    • Microbiome therapies
    • Synthetic biology
    • Biomaterials & drug delivery systems

4. By Disease Area

  • Oncology (immunotherapy, targeted therapy)
  • Rare diseases (orphan indications)
  • Neurology (Alzheimer’s, Parkinson’s)
  • Infectious diseases (vaccines, antivirals)
  • Metabolic & cardiovascular diseases
  • Regenerative medicine

5. By Business/Market Impact

  • Financing news – IPOs, venture funding, M&A.
  • Partnerships & licensing – pharma-biotech collaborations.
  • Market outlook – pricing, reimbursement, health economics.
  • Manufacturing & supply chain – new facilities, CDMO partnerships.

6. Practical Classification Framework

When you encounter a biotech news article, you can tag it across three dimensions:

  1. Source type (Press release, Journalism, Regulatory, Science)
  2. Content type (Clinical trial, Technology, Business, Regulation)
  3. Domain focus (Therapeutic area, Modality, Market)

For example:

  • “Moderna announces positive Phase III mRNA vaccine results” → Press release | Clinical trial | Infectious disease, RNA therapy
  • “FDA approves CRISPR-based therapy for sickle cell disease” → Regulatory update | Approval | Gene editing, Rare disease

by ChatGPT